Autovance feature of an intraosseous device

Information

  • Patent Grant
  • 11517349
  • Patent Number
    11,517,349
  • Date Filed
    Thursday, September 24, 2020
    4 years ago
  • Date Issued
    Tuesday, December 6, 2022
    2 years ago
Abstract
Devices and methods for an autovance intraosseous device. The autovance intraosseous device can include a trigger activated system or pressure activated system that causes a needle to advance distally for a predetermined distance. The predetermined distance ensures a needle tip extends through the bone cortex, to access the medullary cavity, without penetrating a far wall of the medullary cavity. The advancement can be driven by a spring based system or an electric motor.
Description
SUMMARY

Currently, inserting an intraosseous (“I.O.”) needle often requires a powered drill, or similar powered device that, when activated, drives a needle through a bone layer to access the medullary cavity within. The clinician is required to selectively deactivate the device when they “feel” the needle advance past the relatively hard and compact, cortex layer of the bone and penetrates into the relatively soft, medullary cavity of the bone. However, the relative density of the bone cortex compared with the medullary cavity can vary depending on the bone, size of medullary space, and the patient, e.g. age, health, etc. Accordingly, the clinician relies on a subjective assessment of a lack of resistance in order to determine if the medullary cavity has been successfully accessed. Further, the clinician relies on a subjective assessment to ensure that the needle does not advance through the medullary space and penetrate the far wall of the medullary cavity.


Briefly summarized, embodiments disclosed herein are directed to apparatus and methods for an “autovance” intraosseous device. The device includes a trigger activated system or pressure activated system that causes a needle to advance distally a predetermined distance. The relative thickness of a bone cortex does not vary greatly between patients. Accordingly, the predetermined distance is sufficient to ensure a needle tip extends through the bone cortex, to access the medullary cavity, without penetrating a far wall of the medullary cavity. In some embodiments, the predetermined distance can be between 1 cm and 3 cm, however lesser or greater distances are also contemplated. The advancement can be driven by a spring based system or an electric motor.


Disclosed herein is an autovance intraosseous access device including, a housing, a drive screw, threadably engaged with the housing, the drive screw configured to advance a predetermined distance along a longitudinal axis, and an access assembly coupled to a distal end of the drive screw.


In some embodiments, the autovance intraosseous access device further includes a drive spring or an electric motor configured to rotate the drive screw. In some embodiments, the autovance intraosseous access device further includes a housing nut coupled with the housing in a fixed relationship and configured to threadably engage the drive screw with the housing. In some embodiments, the autovance intraosseous access device further includes a drive spindle rotatably coupled to the housing and slidably engaged with the drive screw to allow the drive screw to advance along the longitudinal axis.


In some embodiments, the autovance intraosseous access device further includes a locking piece coupled to the drive spindle and transitionable between a locked position to inhibit rotation of the drive spindle and an unlocked position to allow the drive spindle to rotate about the longitudinal axis. In some embodiments, a distal surface of the locking piece includes a protrusion, recess, detent, hex-key engagement, star ratchet engagement, or “lock and key” engagement, configured to engage a surface of the housing in the locked position. In some embodiments, the autovance intraosseous access device further includes a drive nut threadably engaged with the drive screw, slidably engaged with the housing and configured to engage the locking piece to transition the locking piece from the locked position to the unlocked position. In some embodiments, the autovance intraosseous access device further includes a drive screw head fixed coupled to a proximal end of the drive screw and configured to engage the housing to inhibit further longitudinal movement of the drive screw. In some embodiments, the predetermined distance is between 1 cm and 3 cm.


Also disclosed is an intraosseous access device including, a housing, a drive screw rotatably engaged with the housing and threadably engaged with an access assembly nut, the drive screw configured to advance the access assembly nut distally by a predetermined distance, and an access assembly coupled to a distal end of the access assembly nut.


In some embodiments, the intraosseous access device further includes a drive spring or an electric motor configured to rotate the drive screw. The drive spring or electric motor is actuated by a trigger actuator where a pressure is applied to the trigger or a pressure actuator where a pressure is applied to a distal tip of the access assembly. The access assembly nut is slidably engaged with the housing to allow longitudinal movement and to inhibit rotational movement of the access assembly nut. In some embodiments, the predetermined distance is between 1 cm and 3 cm.


Also disclosed is an intraosseous access device including, a housing, a drive screw fixedly engaged with the housing and threadably engaged with an access assembly nut, an access assembly coupled to a distal end of the access assembly nut, and an energy source configured to rotate the access assembly nut to advance the access assembly distally a predetermined distance.


In some embodiments, the energy source is a drive spring or an electric motor. The energy source is actuated by a trigger actuator, or a pressure actuator that is actuated when a longitudinal pressure is applied to the access assembly. In some embodiments, the predetermined distance is between 1 cm and 3 cm.


Also disclosed is an intraosseous access device including, a housing, a drive bolt slidably engaged with the housing along a longitudinal axis by a predetermined distance, a biasing member configured to urge the drive bolt distally, an access assembly coupled to a distal end of the drive bolt, and an energy source configured to transition the drive bolt between a locked position and an unlocked position.


In some embodiments, the energy source is a drive spring or an electric motor. The energy source is configured to rotate the drive bolt to transition the drive bolt between a locked position where longitudinal movement of the drive bolt is inhibited, and an unlocked position where the drive bolt can slide longitudinally. In some embodiments, the intraosseous access device further includes a protrusion engaging a surface of a bolt head of the drive bolt in the locked position and the protrusion aligning with a slot extending longitudinally through the bolt head in the unlocked position. The drive bolt engages a portion of the housing or a housing nut to inhibit further distal movement along a longitudinal axis. In some embodiments, the predetermined distance is between 1 cm and 3 cm.


Also disclosed is a method of accessing a medullary cavity including, actuating an energy source, rotating a drive screw, and advancing the drive screw, having an access assembly coupled thereto, a predetermined distance along a longitudinal axis.


In some embodiments, the method further includes actuating a trigger, or applying a longitudinal pressure to the access assembly, to actuate the energy source. In some embodiments, applying a longitudinal pressure to the access assembly includes sliding the drive screw proximally to transition a locking piece from a locked position to an unlocked position, the drive screw including a drive nut threadably engaged therewith and configured to abut against the locking piece. The locking piece engages a surface of a housing in the locked position, the locking piece including one of a protrusion, recess, detent, star ratchet engagement, hex-key engagement, or a “lock and key” engagement to inhibit movement relative to the housing.


In some embodiments, the method further includes rotating a drive spindle coupled to the locking piece, to rotate the drive screw, the locking piece configured to inhibit rotation of the drive spindle in the locked position and allow rotation of the drive spindle in the unlocked position. In some embodiments, a drive screw head, coupled to the drive screw, defines a facet that is slidably engaged with the drive spindle to allow longitudinal movement of the drive screw relative to the drive spindle, and to inhibit rotational movement of the drive screw relative to the drive spindle. The drive screw head engages one of a housing or a housing nut to inhibit further longitudinal movement. The energy source is one of a drive spring or an electric motor. In some embodiments, the predetermined distance is between 1 cm and 3 cm.


Also disclosed is a method of accessing a medullary cavity including, actuating an energy source, rotating a drive screw, and advancing an access assembly nut a predetermined distance along a longitudinal axis, the access assembly nut threadably engaged with the drive screw and including a facet that is slidably engaged with a housing and configured to inhibit rotational movement of the access assembly nut relative to the housing, the access assembly nut including an access assembly coupled to a distal end thereof.


In some embodiments, actuating an energy source includes actuating a trigger or applying a pressure to a distal tip of the access assembly. The energy source is one of a drive spring or an electric motor. In some embodiments, the predetermined distance is between 1 cm and 3 cm.


Also disclosed is a method of accessing a medullary cavity including, actuating an energy source, rotating an access assembly nut including an access assembly coupled to a distal end thereof, the access assembly threadably engaged with a drive screw, and advancing the access assembly a predetermined distance along a longitudinal axis.


In some embodiments, actuating an energy source includes actuating a trigger or applying a pressure to a distal tip of the access assembly. The energy source is one of a drive spring or an electric motor. In some embodiments, the predetermined distance is between 1 cm and 3 cm.


Also disclosed is a method of accessing a medullary cavity including, actuating an energy source, rotating a drive bolt to an unlocked position, and urging the drive bolt distally a predetermined distance, the drive bolt including an access assembly coupled to a distal end thereof.


In some embodiments, actuating an energy source includes actuating a trigger or applying a pressure to a distal tip of the needle. The energy source is one of a drive spring or an electric motor. In some embodiments, the method further includes a biasing member configured to urge the drive bolt distally. Rotating a drive bolt to an unlocked position includes aligning a slot extending longitudinally through a drive bolt head with a protrusion. The drive bolt head engages one of a housing or a housing nut to inhibit further longitudinal movement. In some embodiments, the predetermined distance is between 1 cm and 3 cm.





DRAWINGS

A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 illustrates an exploded view of an embodiment of an intraosseous access system, wherein an access assembly subset of the system is depicted slightly enlarged and in elevation, and an automated driver component is depicted in perspective, in accordance with embodiments disclosed herein.



FIG. 2 illustrates an intraosseous access system, in accordance with embodiments disclosed herein.



FIG. 3 illustrates an intraosseous access system, in accordance with embodiments disclosed herein.



FIGS. 4A-4B illustrate an intraosseous access system, in accordance with embodiments disclosed herein.



FIG. 5 illustrates an intraosseous access system, in accordance with embodiments disclosed herein.



FIG. 6 illustrates an intraosseous access system, in accordance with embodiments disclosed herein.





DESCRIPTION

Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.


Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.


With respect to “proximal,” a “proximal portion” or a “proximal end portion” of, for example, a needle disclosed herein includes a portion of the needle intended to be near a clinician when the needle is used on a patient. Likewise, a “proximal length” of, for example, the needle includes a length of the needle intended to be near the clinician when the needle is used on the patient. A “proximal end” of, for example, the needle includes an end of the needle intended to be near the clinician when the needle is used on the patient. The proximal portion, the proximal end portion, or the proximal length of the needle can include the proximal end of the needle; however, the proximal portion, the proximal end portion, or the proximal length of the needle need not include the proximal end of the needle. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the needle is not a terminal portion or terminal length of the needle.


With respect to “distal,” a “distal portion” or a “distal end portion” of, for example, a needle disclosed herein includes a portion of the needle intended to be near or in a patient when the needle is used on the patient. Likewise, a “distal length” of, for example, the needle includes a length of the needle intended to be near or in the patient when the needle is used on the patient. A “distal end” of, for example, the needle includes an end of the needle intended to be near or in the patient when the needle is used on the patient. The distal portion, the distal end portion, or the distal length of the needle can include the distal end of the needle; however, the distal portion, the distal end portion, or the distal length of the needle need not include the distal end of the needle. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the needle is not a terminal portion or terminal length of the needle.


As shown in FIG. 1, and to assist in the description of embodiments described herein, a longitudinal axis extends substantially parallel to an axial length of a needle 204 extending from the driver 101. A lateral axis extends normal to the longitudinal axis, and a transverse axis extends normal to both the longitudinal and lateral axes. As used herein, the term “spring” can include any biasing member including compression springs, torsion springs, flat springs, or the like formed from metal, alloys, plastics, polymers, elastomers, rubber, silicone, composites, combinations thereof, or the like.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.


The present disclosure relates generally to intraosseous (10) access devices, systems, and methods thereof. FIG. 1 shows an exploded view of an exemplary embodiment of an intraosseous access system 100, with some components thereof shown in elevation and another shown in perspective. The intraosseous access system 100 can be used to penetrate skin and underlying hard bone for intraosseous access, such as, for example to access the marrow of the bone and/or a vasculature of the patient via a pathway through an interior of the bone.


In an embodiment, the system includes a driver 101 and an access assembly 109. The driver 101 can be used to rotate, or “drill,” the access assembly 109 into a bone of a patient. In embodiments, the driver 101 can be automated or manual. In an embodiment, the driver 101 is an automated driver 108. For example, the automated driver 108 can be a drill that achieves high rotational speeds.


The intraosseous access system 100 can further include an obturator assembly 102, a shield 105, and a needle assembly 202, which may be referred to, collectively, as the access assembly 109. The access assembly 109 may also be referred to as an access system. The obturator assembly 102 is referred to as such herein for convenience. In an embodiment, the obturator assembly 102 includes an obturator 104. However, in some embodiments, the obturator 104 may be replaced with a different elongated medical instrument. As used herein, the term “elongated medical instrument” is a broad term used in its ordinary sense that includes, for example, such devices as needles, cannulas, trocars, obturators, stylets, and the like. Accordingly, the obturator assembly 102 may be referred to more generally as an elongated medical instrument assembly. In like manner, the obturator 104 may be referred to more generally as an elongated medical instrument.


In an embodiment, the obturator assembly 102 includes a coupling hub 103 that is attached to the obturator 104 in any suitable manner (e.g., one or more adhesives or overmolding, etc.). The coupling hub 103 can be configured to interface with the driver 101. The coupling hub 103 may alternatively be referred to as an obturator hub 103 or, more generally, as an elongated instrument hub 103.


In an embodiment, the shield 105 is configured to couple with the obturator 104. The coupling can permit relative longitudinal movement between the obturator 104 and the shield 105, such as sliding, translating, or other movement along an axis of elongation (i.e., axial movement), when the shield 105 is in a first operational mode, and can prevent the same variety of movement when the shield 105 is transitioned to a second operational mode. For example, as further discussed below, the shield 105 may couple with the obturator 104 in a manner that permits longitudinal translation when the obturator 104 maintains the shield 105 in an unlocked state, and when the obturator 104 is moved to a position where it no longer maintains the shield in the unlocked state, the shield 105 may automatically transition to a locked state in which little or no translational movement is permitted between the shield 105 and the obturator 104. Stated otherwise, the shield 105 may be longitudinally locked to a fixed or substantially fixed longitudinal orientation relative to the obturator 104 at which the shield 105 inhibits or prevents inadvertent contact with a distal tip of the obturator, as further discussed below. In various embodiments, the shield 105 may be configured to rotate relative to the obturator 104 about a longitudinal axis of the obturator 104 in one or more of the unlocked or locked states.


With continued reference to FIG. 1, the needle assembly 202 is referred to as such herein for convenience. In an embodiment, the needle assembly 202 includes a needle 204. However, in various other embodiments, the needle 204 may be replaced with a different instrument, such as, for example, a cannula, a tube, or a sheath, and/or may be referred to by a different name, such as one or more of the foregoing examples. Accordingly, the needle assembly 202 may be referred to more generally as a cannula assembly or as a tube assembly. In like manner, the needle 204 may be referred to more generally as a cannula.


In an embodiment, the needle assembly 202 includes a needle hub 203 that is attached to the needle 204 in any suitable manner. The needle hub 203 can be configured to couple with the obturator hub 103 and may thereby be coupled with the driver 101. The needle hub 203 may alternatively be referred to as a cannula hub 203.


In an embodiment, the shield 105 is configured to couple with the needle hub 203. The coupling can prevent relative axial or longitudinal movement between the needle hub 203 and the shield 105, such as sliding, translating, or the like, when the shield 105 is in the first operational mode, and can permit the shield 105 to decouple from the needle hub 203 when the shield 105 is transitioned to the second operational mode. For example, as further discussed below, the shield 105 may couple with the needle hub 203 so as to be maintained at a substantially fixed longitudinal position relative thereto when the obturator 104 maintains the shield 105 in the unlocked state, and when the obturator 104 is moved to a position where it no longer maintains the shield in the unlocked state, the shield 105 may automatically transition to a locked state relative to the obturator 104, in which state the shield 105 also decouples from the needle hub 203.


In an embodiment, the shield 105 can be coupled with the obturator 104, the obturator 104 can be inserted into the needle 204, and the obturator hub 103 can be coupled to the needle hub 203 to assemble the access assembly 109. In an embodiment, a cap 107 may be provided to cover at least a distal portion of the needle 204 and the obturator 104 prior to use of the access assembly 109. For example, in an embodiment, a proximal end of the cap 107 can be coupled to the obturator hub 103.


With continued reference to FIG. 1, the automated driver 108 may take any suitable form. The driver 108 may include a handle 110 that may be gripped by a single hand of a user. The driver 108 may further include an actuator 111, e.g. trigger actuator, of any suitable variety via which a user may selectively actuate the driver 108 to effect rotation of a coupling interface 112. For example, the actuator 111 may comprise a button, as shown, or a switch or other mechanical or electrical element for actuating the driver 108. In an embodiment, the coupling interface 112 is formed as a socket 113 that defines a cavity 114. The coupling interface 112 can be configured to couple with the obturator hub 103. In an embodiment, the socket 113 includes sidewalls that substantially define a hexagonal cavity into which a hexagonal protrusion of the obturator hub 103 can be received. Other suitable connection interfaces are contemplated.


The automated driver 108 can include an energy source 115 of any suitable variety that is configured to energize the rotational movement of the coupling interface 112. For example, in some embodiments, the energy source 115 may comprise one or more batteries that provide electrical power for the automated driver 108. In other embodiments, the energy source 115 can comprise one or more springs (e.g., a coiled spring) or other biasing member that may store potential mechanical energy that may be released upon actuation of the actuator 111.


The energy source 115 may be coupled with the coupling interface 112 in any suitable manner. For example, in an embodiment, the automated driver 108 includes an electrical, mechanical, or electromechanical coupling 116 to a gear assembly 117. In some embodiments, the coupling 116 may include an electrical motor that generates mechanical movement from electrical energy provided by an electrical energy source 115. In other embodiments, the coupling 116 may include a mechanical linkage that mechanically transfers rotational energy from a mechanical (e.g., spring-based) energy source 115 to the gear assembly 117. The automated driver 108 can include a mechanical coupling 118 of any suitable variety to couple the gear assembly 117 with the coupling interface 112. In other embodiments, the gear assembly 117 may be omitted.


In embodiments, the automated driver 108 can rotate the coupling interface 112, and thereby, can rotate the access assembly 109 at rotational speeds significantly greater than can be achieved by manual rotation of the access assembly 109. For example, in various embodiments, the automated driver 108 can rotate the access assembly 109 at speeds of between 200 and 3,000 rotations per minute (rpm). However, it will be appreciated that lesser or greater rotational speeds are also contemplated.


Further details and embodiments of the intraosseous access system 100 can be found in WO 2018/075694, WO 2018/165334, WO 2018/165339, and US 2018/0116693, each of which is incorporated by reference in its entirety into this application.


In an embodiment, the intraosseous access system 100 further includes an advancement assembly disposed between the energy source 115 and the driver coupling interface 112, and operably coupled therewith. When the intraosseous access system 100 is activated, the advancement assembly advances the access assembly 109 a predetermined distance relative to the driver 101, through the longitudinal axis. Since the thickness of the bone cortex is similar between patients, advancing the access assembly 109 the predetermined distance will ensure the tip of the needle 204 advances sufficiently into the medullary cavity to provide access thereto, without impinging a far wall, termed “backwalling.” In an embodiment, the predetermined distance can be between 1 cm and 3 cm, however lesser or greater distances are also contemplated.


In an embodiment, the intraosseous access system 100 is trigger activated, whereby once triggered by a user, the advancement assembly advances the access assembly 109 the predetermined distance before automatically stopping any further advancement. In an embodiment, the intraosseous access system 100 is pressure activated, for example when a pressure is exerted on the needle 204, such as when the needle is pressed against an outer wall of the bone. Once activated, the advancement assembly advances the access assembly 109 the predetermined distance before automatically stopping any further advancement.



FIG. 2 shows an embodiment of an intraosseous access system 200, including a driver 201, an energy source 215, and an advancement assembly 210. The advancement assembly 210 includes a drive screw 220 extending from a proximal end 222 to a distal end 224 and including a threaded portion 228, and a drive screw head 212 disposed at a proximal end thereof. The drive screw 220 is coupled with an energy source 215 such that the energy source 215 can cause the drive screw 220 to rotate about a longitudinal axis. As described herein the energy source 215 can be an electric motor, battery, torsion spring, combinations thereof, or the like, or similar electrically, chemically, or kinetically powered device that provides sufficient rotational speed and torque. It will be appreciated that the drive screw 220 and energy source 215 can be coupled by way of a gear mechanism, e.g. gear assembly 117.


The drive screw 220 is threadably engaged with a housing nut 230, or similar female threaded structure that engages the male threaded portion 228 of the drive screw 220. The housing nut 230 is fixedly coupled to the driver 201 so as to prevent any relative movement between the housing nut 230 and the driver 201. A distal end 224 of the drive screw 220 is coupled with a socket 113 that engages an access assembly 109. In use, a distal end 240 of the driver 201 is positioned against the skin surface 70 of the patient and the energy source 215 is activated. As discussed herein, the energy source is trigger activated, pressure activated, or combinations thereof. The energy source 215 rotates the drive screw 220, socket 113, and advancement assembly 109 together. The threaded portion 228 of the drive screw 220 engages the housing nut 230 and advances the drive screw 220, socket 113, and advancement assembly 109 in a distal direction relative to the driver 201.


The driver 201 continues to rotate the drive screw 220 until the drive screw head 212 contacts the housing nut 230 and prevents any further distal advancement. In an embodiment, the intraosseous access system 200 includes a switch that shuts off the energy source 215, e.g. an electric motor, when the drive screw head 212 advances a predetermined distance. It will be appreciated that the distance of distal travel of the drive screw 220 and access assembly 109 is sufficient to advance the tip 205 of the needle 204 through the cortex 80 of the bone to access the medullary cavity 90.



FIG. 3 shows an embodiment of an intraosseous access system 300, including a driver 301, an energy source 315, and an advancement assembly 310. The advancement assembly includes a drive screw 320 extending from a proximal end 322 to a distal end 324. The drive screw 320 includes a threaded portion 328 and a drive screw head 312 disposed at a proximal end thereof. The drive screw 320 is coupled with an energy source 315 such that the energy source 315 can cause the drive screw 320 to rotate about a longitudinal axis. As described herein the energy source 315 can be an electric motor, torsion spring, or the like. The energy source 315 is fixed to a proximal end of the driver 301 such that the drive screw 320 remains stationary relative to the driver 301 along a longitudinal axis.


The drive screw 320 is threadably engaged with an access assembly access assembly nut 330, or similar female threaded structure that engages the male threaded portion 328 of the drive screw 320. The access assembly nut 330 defines one or more side facets 332 that engages an inner wall 308 of the driver 301 such that the access assembly nut 330 is prevented from rotating about a longitudinal axis but is able to slide along a longitudinal axis, relative to the driver 301. An access assembly 109 is coupled to a distal surface of the access assembly nut 330 and optionally includes socket 113, or the like, to secure the access assembly 109 to the access assembly nut 330.


In use, a distal end 340 of the driver 301 is positioned against the skin surface 70 of the patient and the energy source 315 is activated. As discussed herein, the energy source is trigger activated, pressure activated, or combinations thereof. The energy source 315 rotates the drive screw 320 which engages the access assembly nut 330 and drives the access assembly nut 330 and access assembly 109 in a distal direction relative to the driver 301. The energy source 315 continues to rotate the drive screw 320 until the access assembly nut 330 reaches a distal end 324 of the threaded portion 328 and prevents any further distal advancement. In an embodiment, the intraosseous access system 300 includes a switch that shuts off the energy source 315, e.g. an electric motor, when the access assembly nut 330 advances a predetermined distance. It will be appreciated that the distance of distal travel of the access assembly nut 330 and access assembly 109 is sufficient to advance the needle tip 205 through the bone cortex 80 to access the medullary cavity 90, i.e. to provide fluid communication between a lumen of the needle and the medullary cavity 90.



FIGS. 4A-4B shows an embodiment of an intraosseous access system 400, including a driver 401, an energy source 415, and an advancement assembly 410. FIG. 4A shows a retracted position before deployment, FIG. 4B shows a deployed position when the needle has been inserted into the medullary cavity 90. The advancement assembly 410 includes a drive screw 420 extending from a proximal end 422 to a distal end 424 and including a threaded portion 428. The drive screw 420 is attached to the driver 401 so as to prevent any relative movement between the drive screw 420 and the driver 401. A access assembly nut 430 is rotatably coupled with an energy source 415, e.g. electric motor, torsion spring, etc. such that when the energy source 415 is activated, the access assembly nut 430 is rotated relative to the drive screw 420. An access assembly 109 is coupled to a distal surface of the access assembly nut 430 and optionally includes socket 113, or the like, to secure the access assembly 109 to the access assembly nut 430. In an embodiment, the access assembly nut 430 is slidably engaged with the energy source 415 such that the access assembly nut 430 can move along a longitudinal axis relative to the energy source 415. In an embodiment, the energy source 415 is slidably engaged with the driver 401 such that the energy source 415 and access assembly nut 430 can move together along a longitudinal axis relative to the driver 401.


In use, a distal end 440 of the driver 401 is positioned against the skin surface 70 of the patient and the energy source 415 is activated. As discussed herein, the energy source is trigger activated, pressure activated, or combinations thereof. The energy source 415 rotates the access assembly nut 430 and advancement assembly 109 together. The access assembly nut 430 engages the threaded portion 428 of the drive screw 420 and advances the access assembly nut 430 and advancement assembly 109 in a distal direction relative to the driver 401.


The energy source continues to rotate the access assembly nut 430 until the access assembly nut 430 reaches a distal end 424 of the threaded portion 428 and prevents any further distal advancement. In an embodiment, the intraosseous access system 200 includes a switch that shuts off the energy source 415, e.g. an electric motor, when the access assembly nut 430 advances to a predetermined position. It will be appreciated that the distance of distal travel of the access assembly nut 430 and access assembly 109 is sufficient to advance the tip of the needle 204 a predetermined distance, through the cortex 80 of the bone to access the medullary cavity 90.



FIG. 5 shows an embodiment of an intraosseous access device 500, including a driver 501, an energy source 515, and an advancement assembly 510. The advancement assembly 510 includes a drive bolt 520, extending from a proximal end 522 to a distal end 524. The drive bolt 520 includes a bolt head 512 disposed at a proximal end 522 and an access assembly 109 coupled to a distal end 524. Optionally, the access assembly 109 is coupled to the drive bolt 520 using socket 113. The drive bolt 520 is slidably engaged with a housing nut 530, or similar annular structure that surrounds the shaft of bolt 520. The housing nut 530 is attached to the driver 501 so as to prevent any relative movement between the housing nut 530 and the driver 501.


A compression spring 514, or similar biasing member, is compressed between a proximal surface of the bolt head 512 and proximal portion of the driver 501, or energy source 515. The spring 514 and bolt head 512 are held in place by a locking mechanism such as one or more protrusions 516. The locking mechanism can transition between a locked position where distal longitudinal movement of the drive bolt 520 is inhibited, and an unlocked position where the drive bolt 520 can slide longitudinally. In a locked position, the protrusions 516 engage a distal surface of the drive bolt head 512 to inhibit distal longitudinal movement. In the unlocked position, the protrusions 516 are aligned with slots 518 extending longitudinally through the drive bolt head 512 and configured to allow the protrusions to slide therethrough. In an embodiment, the drive bolt 520 can be rotated between a locked position and an unlocked position.


In use, the energy source 515 is activated, either by a trigger or pressure activation as described herein. The energy source 515 rotates the bolt head 512 about a longitudinal axis until the protrusions 516 align with the slots 518. This allows the bolt head 512 to slide, relative to the driver 501, along a longitudinal axis. This also allows the compression spring 514 to expand, urging the drive bolt 520 and access assembly 109 in a distal direction for a predetermined distance, until the bolt head 512 abuts against the housing nut 530, preventing any further distal movement. This forces the needle 204 a predetermined distance through the bone cortex 80 until a distal tip thereof extends sufficiently into the medullary cavity 90. It will be appreciated that other locking mechanisms configured to retain the bold head 512 in the retracted position are also contemplated. Exemplary locking mechanisms can include retractable protrusions that slide radially outward perpendicular to the longitudinal axis, pawls, ratchets, catches, grips, combinations thereof, or the like configured to release the bolt head 512 and allow the spring 514, or similar biasing member, to urge the access assembly 109 distally.



FIG. 6 shows an embodiment of an intraosseous access system 600, which includes a spring driven energy source and a pressure trigger. The intraosseous access system 600 includes an upper housing 602 that engages a lower housing 604 to form a body of driver 601. The driver 601 is substantially radially symmetrical about a longitudinal axis. The upper housing 602 includes an energy source 615, e.g. a drive spring, and a drive spindle 606 that is coupled to the drive spring energy source 615. In an embodiment, the drive spring is a torsion spring, however it will be appreciated that the energy source 615 can also include flat springs, clock springs, electrical motors, and the like, without limitation.


The upper housing 602 and the drive spindle 606 are rotatably engaged such that when the drive spring energy source 615 is activated the drive spindle 606 can rotate freely within the upper housing 602. The drive spindle 606 further includes a centrally disposed, cylindrically shaped cavity 608. A cross-sectional area of the drive spindle cavity 608, extending normal to the longitudinal axis, defines a substantially hexagonal shape that is configured to receive a drive screw head 612. It will be appreciated that the cross-sectional shape of the drive spindle cavity 608 can also include other faceted polygonal cross sectional shapes that are configured to receive the drive screw head 612. In an embodiment, the drive screw head 612 is formed as a single unitary structure with the drive screw 610. In an embodiment, the drive screw head 612 includes a locking nut (not shown) that is threadably engaged with the drive screw 610 and fixed in place so as not to move relative to the drive screw 610. Accordingly, when the drive spring 615 is activated, the drive spindle 606 engages the drive screw head 612 and rotates the drive screw 610. The drive spindle cavity 608 allows the drive screw head 612 to slide relative to the drive spindle 606 along the longitudinal axis.


A distal end of the drive screw 610 engages socket 113, which in turn engages access assembly 109. A housing nut 616 is threadably engaged with the drive screw 610. The housing nut 616 is fixed within the upper housing 602, lower housing 604, or combinations thereof, so as not to move relative to the driver 601. Accordingly, as the drive screw 610 rotates about the longitudinal axis, the threaded engagement with the housing nut 616 causes the drive screw, and access assembly 109, to move longitudinally relative to the driver 601. In an embodiment, the drive screw 610 can advance distally along the longitudinal axis, until the drive screw head 612 engages the housing nut 616, inhibiting further distal movement. In an embodiments, the drive screw can advance a predetermined distance. In an embodiment, the predetermined distance can be between 1 cm and 3 cm, however lesser or greater distances are also contemplated.


The lower housing 604 further includes a centrally disposed, cylindrically shaped cavity 622. A cross-sectional area of the lower housing cavity 622, extending normal to the longitudinal axis, defines a substantially hexagonal shape that is configured to slidably receive a drive nut 620. It will be appreciated that the cross-sectional shape of the lower housing cavity 622 can also include other faceted, polygonal, cross-sectional shapes that are configured to receive the drive nut 620. The drive nut 620 is threadably engaged with the drive screw 610 and disposed adjacent a distal surface of a locking piece 618. Accordingly, when the drive screw 610 rotates, the drive nut 620 is prevented from rotating by the engagement between a facet of the drive nut 620 and a wall surface of the lower housing cavity 622. However, the drive nut 620 is capable of sliding along a longitudinal axis relative to the lower housing 604.


A locking piece 618 is disposed between the drive spindle 606 and the lower housing 604. The locking piece 618 is fixedly attached with a distal end of the drive spindle 606 to prevent any movement of the drive spindle 606 relative to the locking piece 618. Further, the locking piece 618 can transition between a locked position and an unlocked position. For example, a distal surface of the locking piece 618 includes a star ratchet that releasably engages a proximal surface of the lower housing 604. The engagement between the locking piece 618 and the lower housing 604, i.e. the locked position, can be maintained by a biasing member (not shown), which applies a longitudinal distal pressure to locking piece 618, holding it against the lower housing 604, biasing the locking piece 618 towards a locked position. It will be appreciated that the engagement between the distal surface of the locking piece 618 and the proximal surface of the lower housing 604 can include a variety of locking mechanisms, for example, protrusions, detents, recesses, hex-key engagement, or similar “lock and key” engagement, or combinations thereof. Further, the locking piece 618 is slidably engaged with the drive screw 610 such that the drive screw 610 can move along a longitudinal axis relative to the locking piece 618. Accordingly, the locking piece 618 and the drive screw 610 can rotate relative to each other without causing any relative longitudinal movement therebetween.


In use, the intraosseous access system 600 is provided with the drive screw 610 in the retracted position, i.e. with the drive screw head 612 adjacent a proximal end of drive spindle cavity 608. The access assembly 109 is disposed within the lower housing cavity 622 with the drive nut 620 disposed adjacent the locking piece 618. In an embodiment, a distal tip 205 of needle 204 can extend beyond a distal surface 630 of the lower housing 604. In an embodiment, a distal tip 205 of needle 204 is disposed within the lower housing 604. The user can place the distal surface 630 of the driver 601 against the skin surface 70 of the patient. The tip 205 of the needle 204 penetrates the skin surface and contacts a surface of the bone cortex 80.


The user then applies sufficient pressure to the proximal surface 632 of the driver 601 so that the needle tip 205 presses against the bone cortex 80. This causes the drive screw 610 and drive nut 620 to slide, relative to the lower housing 604, and press against the locking piece 618. The locking piece can slide longitudinal and disengage the locking piece 618 from the lower housing 604. The energy source 615, e.g. drive spring, can then rotate the locking piece 618 and drive spindle 606 relative to the upper housing 602. The drive screw head 612 and drive screw 610 can then rotate relative to the driver 601, and engage the housing nut 616 to urge the drive screw 610 and access assembly 109 in a distal direction. This urges the needle 204 through bone cortex 80 so that the needle tip 205 can access the medullary cavity 90.


Advantageously, the pressure activation of the intraosseous access device 600 provides a quick and easy deployment of the access assembly 109. There is no need for any assembly of parts, needles, or the like and deployment involves only a single step process of aligning the needle tip and applying pressure to a proximal end 632. Further, applying pressure as such, stabilizes the device against the patient and provides sufficient counter-resistance to drive the needle 204 through the bone cortex 90. The rotation of the drive screw 612 causes the access assembly 109 to rotate, which also provides a drilling action, together with the distal force, and further facilitates driving the needle 204 through the bone cortex 80. In an embodiment, the coupling between the access assembly 109 and the drive screw 612 can allow for free rotation therebetween to offset and rotational movement and only provide distal force to provide a cleaner puncture through the bone cortex 80. Advantageously, an electric motor energy source 615 can provide a consistent force between the start and finish of the process. Advantageously, a spring driven energy source 615 can be stored for a longer time without loss of power, accordingly, intraosseous access systems 600 would not have to be replaced as often.


While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.

Claims
  • 1. An autovance intraosseous access device, comprising: a housing;a drive screw, threadably engaged with the housing, the drive screw configured to advance a predetermined distance along a longitudinal axis;a drive spindle rotatably coupled to the housing and slidably engaged with the drive screw to allow the drive screw to advance along the longitudinal axis;a locking piece coupled to the drive spindle and transitionable between a locked position to inhibit rotation of the drive spindle and an unlocked position to allow the drive spindle to rotate about the longitudinal axis;a drive nut threadably engaged with the drive screw, slidably engaged with the housing and configured to engage the locking piece to transition the locking piece from the locked position to the unlocked position; andan access assembly coupled to a distal end of the drive screw, the access assembly comprising an obturator assembly, a shield, and a needle assembly.
  • 2. The autovance intraosseous access device according to claim 1, further including a drive spring or an electric motor configured to rotate the drive screw.
  • 3. The autovance intraosseous access device according to claim 1, further including a housing nut coupled with the housing in a fixed relationship and configured to threadably engage the drive screw with the housing.
  • 4. The autovance intraosseous access device according to claim 1, wherein a distal surface of the locking piece includes a protrusion, recess, detent, hex-key engagement, star ratchet engagement, or “lock and key” engagement, configured to engage a surface of the housing in the locked position.
  • 5. The autovance intraosseous access device according to claim 1, further including a drive screw head fixedly coupled to a proximal end of the drive screw and configured to engage the housing to inhibit further longitudinal movement of the drive screw.
  • 6. The autovance intraosseous access device according to claim 1, wherein the predetermined distance is between 1 cm and 3 cm.
  • 7. An intraosseous access device, comprising: a housing;a drive bolt slidably engaged with the housing along a longitudinal axis by a predetermined distance;a biasing member configured to urge the drive bolt distally;an access assembly coupled to a distal end of the drive bolt, the access assembly comprising an obturator assembly, a shield, and a needle assembly; andan energy source configured to rotate the drive bolt to transition the drive bolt between a locked position where longitudinal movement of the drive bolt is inhibited, and an unlocked position where the drive bolt can slide longitudinally.
  • 8. The intraosseous access device according to claim 7, wherein the energy source is a drive spring or an electric motor.
  • 9. The intraosseous access device according to claim 7, further including a protrusion engaging a surface of a bolt head of the drive bolt in the locked position and the protrusion aligning with a slot extending longitudinally through the bolt head in the unlocked position.
  • 10. The intraosseous access device according to claim 7, wherein the drive bolt engages a portion of the housing or a housing nut to inhibit further distal movement along the longitudinal axis.
  • 11. The intraosseous access device according to claim 7, wherein the predetermined distance is between 1 cm and 3 cm.
  • 12. An intraosseous access device, comprising: a housing;a drive bolt slidably engaged with the housing along a longitudinal axis by a predetermined distance;a biasing member configured to urge the drive bolt distally;an access assembly coupled to a distal end of the drive bolt, the access assembly comprising an obturator assembly, a shield, and a needle assembly;an energy source configured to transition the drive bolt between a locked position and an unlocked position; anda protrusion engaging a surface of a bolt head of the drive bolt in the locked position, the protrusion aligning with a slot extending longitudinally through the bolt head in the unlocked position.
PRIORITY

This application claims the benefit of priority to U.S. Provisional Application No. 62/907,438, filed Sep. 27, 2019, which is incorporated by reference in its entirety into this application.

US Referenced Citations (319)
Number Name Date Kind
2773501 Young Dec 1956 A
3071135 Baldwin et al. Jan 1963 A
3804544 Adams Apr 1974 A
3811442 Maroth May 1974 A
3815605 Schmidt et al. Jun 1974 A
3991765 Cohen Nov 1976 A
4266555 Jamshidi May 1981 A
4314565 Lee Feb 1982 A
4383530 Bruno May 1983 A
4736742 Alexson et al. Apr 1988 A
4889529 Haindl Dec 1989 A
4952207 Lemieux Aug 1990 A
4964854 Luther Oct 1990 A
4969870 Kramer et al. Nov 1990 A
5040542 Gray Aug 1991 A
5042558 Hussey et al. Aug 1991 A
5053017 Chamuel Oct 1991 A
5122114 Miller et al. Jun 1992 A
5207697 Carusillo et al. May 1993 A
5263939 Wortrich Nov 1993 A
5290267 Zimmermann Mar 1994 A
5312364 Jacobs May 1994 A
5332398 Miller et al. Jul 1994 A
5364367 Banks et al. Nov 1994 A
5372583 Roberts et al. Dec 1994 A
5406940 Melzer et al. Apr 1995 A
5451210 Kramer et al. Sep 1995 A
5554154 Rosenberg Sep 1996 A
5575780 Saito Nov 1996 A
5591188 Waisman Jan 1997 A
5601559 Melker et al. Feb 1997 A
5667509 Westin Sep 1997 A
5688249 Chang et al. Nov 1997 A
5779708 Wu Jul 1998 A
5817052 Johnson et al. Oct 1998 A
5853393 Bogert Dec 1998 A
5868711 Kramer et al. Feb 1999 A
5885293 McDevitt Mar 1999 A
5927976 Wu Jul 1999 A
5960797 Kramer et al. Oct 1999 A
5967143 Klappenberger Oct 1999 A
6117108 Woehr et al. Sep 2000 A
6135769 Kwan Oct 2000 A
6199664 Tkaczyk et al. Mar 2001 B1
6210373 Allmon Apr 2001 B1
6228088 Miller et al. May 2001 B1
6247928 Meller et al. Jun 2001 B1
6270484 Yoon Aug 2001 B1
6273715 Meller et al. Aug 2001 B1
6419490 Kitchings Weathers, Jr. Jul 2002 B1
6458117 Pollins, Sr. Oct 2002 B1
6527778 Athanasiou et al. Mar 2003 B2
6602214 Heinz et al. Aug 2003 B2
6626887 Wu Sep 2003 B1
6629959 Kuracina et al. Oct 2003 B2
6641395 Kumar et al. Nov 2003 B2
6652490 Howell Nov 2003 B2
6692471 Boudreaux Feb 2004 B2
6761726 Findlay et al. Jul 2004 B1
6814734 Chappuis et al. Nov 2004 B2
6830562 Mogensen et al. Dec 2004 B2
6875219 Arramon et al. Apr 2005 B2
6905486 Gibbs Jun 2005 B2
6916292 Morawski et al. Jul 2005 B2
6984213 Horner et al. Jan 2006 B2
6997907 Safabash et al. Feb 2006 B2
7112191 Daga Sep 2006 B2
7135031 Flint Nov 2006 B2
7214208 Vaillancourt et al. May 2007 B2
7347838 Kulli Mar 2008 B2
7347840 Findlay et al. Mar 2008 B2
7407493 Cane′ Aug 2008 B2
7458954 Ferguson et al. Dec 2008 B2
7513888 Sircom et al. Apr 2009 B2
7530965 Villa et al. May 2009 B2
7534227 Kulli May 2009 B2
7569033 Greene et al. Aug 2009 B2
7582102 Heinz et al. Sep 2009 B2
7588559 Aravena et al. Sep 2009 B2
7658725 Bialecki et al. Feb 2010 B2
7670328 Miller Mar 2010 B2
7699807 Faust et al. Apr 2010 B2
7699850 Miller Apr 2010 B2
7736332 Carlyon et al. Jun 2010 B2
7749225 Chappuis et al. Jul 2010 B2
7798994 Brimhall Sep 2010 B2
7811260 Miller et al. Oct 2010 B2
7815642 Miller Oct 2010 B2
7828774 Harding et al. Nov 2010 B2
7833204 Picha Nov 2010 B2
7842038 Haddock et al. Nov 2010 B2
7850620 Miller et al. Dec 2010 B2
7850650 Breitweiser Dec 2010 B2
D633199 MacKay et al. Feb 2011 S
7899528 Miller et al. Mar 2011 B2
7905857 Swisher Mar 2011 B2
7951089 Miller May 2011 B2
7955297 Radmer et al. Jun 2011 B2
7972339 Nassiri et al. Jul 2011 B2
7976502 Baid Jul 2011 B2
8038664 Miller et al. Oct 2011 B2
8043253 Kraft et al. Oct 2011 B2
8043265 Abe et al. Oct 2011 B2
8142365 Miller Mar 2012 B2
8152771 Mogensen et al. Apr 2012 B2
8162904 Takano et al. Apr 2012 B2
8167899 Justis et al. May 2012 B2
8235945 Baid Aug 2012 B2
8246584 Aravena et al. Aug 2012 B2
8273053 Saltzstein Sep 2012 B2
8292891 Browne et al. Oct 2012 B2
8308693 Miller et al. Nov 2012 B2
8333769 Browne et al. Dec 2012 B2
8356598 Rumsey Jan 2013 B2
8357163 Sidebotham et al. Jan 2013 B2
8388541 Messerly et al. Mar 2013 B2
8388623 Browne et al. Mar 2013 B2
8414539 Kuracina et al. Apr 2013 B1
8419683 Miller et al. Apr 2013 B2
8480632 Miller et al. Jul 2013 B2
8480672 Browne et al. Jul 2013 B2
8486027 Findlay et al. Jul 2013 B2
8506568 Miller Aug 2013 B2
8535271 Fuchs et al. Sep 2013 B2
8562615 Browne et al. Oct 2013 B2
8641715 Miller Feb 2014 B2
8647257 Jansen et al. Feb 2014 B2
8656929 Miller et al. Feb 2014 B2
8657790 Tai et al. Feb 2014 B2
8663231 Browne et al. Mar 2014 B2
8668698 Miller et al. Mar 2014 B2
8684978 Miller et al. Apr 2014 B2
8690791 Miller Apr 2014 B2
8715287 Miller May 2014 B2
8771230 White et al. Jul 2014 B2
8781555 Burnside et al. Jul 2014 B2
8801663 Woehr Aug 2014 B2
8812101 Miller et al. Aug 2014 B2
8814835 Baid Aug 2014 B2
8821493 Anderson Sep 2014 B2
8828001 Stearns et al. Sep 2014 B2
8849382 Cox et al. Sep 2014 B2
8870872 Miller Oct 2014 B2
8936575 Moulton Jan 2015 B2
8944069 Miller et al. Feb 2015 B2
8974410 Miller et al. Mar 2015 B2
8998848 Miller et al. Apr 2015 B2
9072543 Miller et al. Jul 2015 B2
9078637 Miller Jul 2015 B2
9149625 Woehr et al. Oct 2015 B2
9173679 Tzachar et al. Nov 2015 B2
9226756 Teisen et al. Jan 2016 B2
9278195 Erskine Mar 2016 B2
9295487 Miller et al. Mar 2016 B2
9302077 Domonkos et al. Apr 2016 B2
9314232 Stark Apr 2016 B2
9314270 Miller Apr 2016 B2
9358348 Weilbacher et al. Jun 2016 B2
9393031 Miller Jul 2016 B2
9414815 Miller et al. Aug 2016 B2
9415192 Kuracina et al. Aug 2016 B2
9421345 Woehr et al. Aug 2016 B2
9427555 Baid Aug 2016 B2
9433400 Miller Sep 2016 B2
9439667 Miller Sep 2016 B2
9439702 Arthur et al. Sep 2016 B2
9445743 Kassab Sep 2016 B2
9451968 Miller et al. Sep 2016 B2
9451983 Windolf Sep 2016 B2
9456766 Cox et al. Oct 2016 B2
9480483 Browne et al. Nov 2016 B2
9492097 Wilkes et al. Nov 2016 B2
9504477 Miller et al. Nov 2016 B2
9521961 Silverstein et al. Dec 2016 B2
9545243 Miller et al. Jan 2017 B2
9554716 Burnside et al. Jan 2017 B2
9615816 Woodard Apr 2017 B2
9615838 Nino Apr 2017 B2
9623210 Woehr Apr 2017 B2
9636031 Cox May 2017 B2
9636484 Baid May 2017 B2
9649048 Cox et al. May 2017 B2
9681889 Greenhalgh et al. Jun 2017 B1
9687633 Teoh Jun 2017 B2
9717564 Miller et al. Aug 2017 B2
9730729 Kilcoin et al. Aug 2017 B2
9782546 Woehr Oct 2017 B2
9839740 Beamer et al. Dec 2017 B2
9844646 Knutsson Dec 2017 B2
9844647 Knutsson Dec 2017 B2
9872703 Miller et al. Jan 2018 B2
9883853 Woodard et al. Feb 2018 B2
9895512 Kraft et al. Feb 2018 B2
9962211 Csematoni May 2018 B2
10052111 Miller et al. Aug 2018 B2
10092320 Morgan et al. Oct 2018 B2
10159531 Misener et al. Dec 2018 B2
10172538 Kassab Jan 2019 B2
10413211 Kassab Sep 2019 B2
10449330 Newman et al. Oct 2019 B2
10893887 Blanchard Jan 2021 B2
10980522 Muse Apr 2021 B2
20030060781 Mogensen et al. Mar 2003 A1
20030225344 Miller Dec 2003 A1
20030225411 Miller Dec 2003 A1
20030229308 Tsais et al. Dec 2003 A1
20040010236 Morawski et al. Jan 2004 A1
20040059317 Hermann Mar 2004 A1
20040220497 Findlay et al. Nov 2004 A1
20040243135 Koseki Dec 2004 A1
20050035014 Cane Feb 2005 A1
20050101912 Faust et al. May 2005 A1
20050113866 Heinz et al. May 2005 A1
20050131345 Miller Jun 2005 A1
20060015066 Turieo et al. Jan 2006 A1
20060025723 Ballarini Feb 2006 A1
20070049945 Miller Mar 2007 A1
20070191772 Wojcik Aug 2007 A1
20070270775 Miller et al. Nov 2007 A1
20080015467 Miller Jan 2008 A1
20080154304 Crawford et al. Jun 2008 A1
20080208136 Findlay et al. Aug 2008 A1
20080215056 Miller et al. Sep 2008 A1
20080221580 Miller et al. Sep 2008 A1
20080257359 Rumsey Oct 2008 A1
20090048575 Waters Feb 2009 A1
20090054808 Miller Feb 2009 A1
20090093830 Miller Apr 2009 A1
20090204024 Miller Aug 2009 A1
20090306697 Fischvogt Dec 2009 A1
20100004606 Hansen et al. Jan 2010 A1
20100204649 Miller et al. Aug 2010 A1
20100286607 Saltzstein Nov 2010 A1
20100298830 Browne et al. Nov 2010 A1
20100298831 Browne et al. Nov 2010 A1
20100312246 Browne et al. Dec 2010 A1
20110004163 Vaidya Jan 2011 A1
20110028976 Miller Feb 2011 A1
20120202180 Stock et al. Aug 2012 A1
20120203154 Tzachar Aug 2012 A1
20120274280 Yip et al. Nov 2012 A1
20130030439 Browne et al. Jan 2013 A1
20130041345 Kilcoin et al. Feb 2013 A1
20130072938 Browne et al. Mar 2013 A1
20130102924 Findlay et al. Apr 2013 A1
20130158484 Browne et al. Jun 2013 A1
20130178807 Baid Jul 2013 A1
20140031674 Newman et al. Jan 2014 A1
20140031794 Windolf Jan 2014 A1
20140039400 Browne et al. Feb 2014 A1
20140081281 Felder Mar 2014 A1
20140142577 Miller May 2014 A1
20140188133 Misener Jul 2014 A1
20140262408 Woodard Sep 2014 A1
20140262880 Yoon Sep 2014 A1
20140276205 Miller et al. Sep 2014 A1
20140276206 Woodward et al. Sep 2014 A1
20140276471 Emery et al. Sep 2014 A1
20140276833 Larsen et al. Sep 2014 A1
20140276839 Forman et al. Sep 2014 A1
20140343454 Miller et al. Nov 2014 A1
20140343497 Baid Nov 2014 A1
20150011941 Saeki Jan 2015 A1
20150045732 Murphy et al. Feb 2015 A1
20150080762 Kassab et al. Mar 2015 A1
20150126931 Holm et al. May 2015 A1
20150196737 Baid Jul 2015 A1
20150223786 Morgan et al. Aug 2015 A1
20150230823 Morgan et al. Aug 2015 A1
20150238733 Bin Abdulla Aug 2015 A1
20150342615 Keinan et al. Dec 2015 A1
20150342756 Bays et al. Dec 2015 A1
20150351797 Miller et al. Dec 2015 A1
20150366569 Miller Dec 2015 A1
20160022282 Miller et al. Jan 2016 A1
20160022284 Lele et al. Jan 2016 A1
20160058432 Miller Mar 2016 A1
20160066954 Miller et al. Mar 2016 A1
20160136410 Aklog et al. May 2016 A1
20160183974 Miller Jun 2016 A1
20160184509 Miller et al. Jun 2016 A1
20160235949 Baid Aug 2016 A1
20160354539 Tan et al. Dec 2016 A1
20160361519 Teoh et al. Dec 2016 A1
20170020533 Browne et al. Jan 2017 A1
20170020560 Van Citters et al. Jan 2017 A1
20170021138 Sokolski Jan 2017 A1
20170043135 Knutsson Feb 2017 A1
20170105763 Karve et al. Apr 2017 A1
20170136217 Riesenberger et al. May 2017 A1
20170151419 Sonksen Jun 2017 A1
20170156740 Stark Jun 2017 A9
20170156751 Csematoni Jun 2017 A1
20170209129 Fagundes et al. Jul 2017 A1
20170231644 Anderson Aug 2017 A1
20170303962 Browne et al. Oct 2017 A1
20170303963 Kilcoin et al. Oct 2017 A1
20180092662 Rioux et al. Apr 2018 A1
20180116551 Newman et al. May 2018 A1
20180116642 Woodard et al. May 2018 A1
20180116693 Blanchard et al. May 2018 A1
20180117262 Islam May 2018 A1
20180125465 Muse et al. May 2018 A1
20180154112 Chan et al. Jun 2018 A1
20180221003 Hibner et al. Aug 2018 A1
20180242982 Laughlin et al. Aug 2018 A1
20190069812 Isaacson et al. Mar 2019 A1
20190282244 Muse Sep 2019 A1
20200054347 Coppedge et al. Feb 2020 A1
20200054410 Pfotenhauer et al. Feb 2020 A1
20200113584 McGinley et al. Apr 2020 A1
20200129186 Miller et al. Apr 2020 A1
20200197121 Morey et al. Jun 2020 A1
20210093357 Pett et al. Apr 2021 A1
20210093358 Lindekugel et al. Apr 2021 A1
20210322055 Lindekugel et al. Oct 2021 A1
20210375445 Lindekugel et al. Dec 2021 A1
20220240976 Pett et al. Aug 2022 A1
20220249104 Pett et al. Aug 2022 A1
Foreign Referenced Citations (60)
Number Date Country
108742795 Nov 2018 CN
110547847 Dec 2019 CN
0923961 Jun 1999 EP
2390297 Nov 2012 ES
2581548 Nov 1986 FR
2018509969 Apr 2018 JP
1997024151 Jul 1997 WO
1998052638 Feb 1999 WO
2005046769 May 2005 WO
05041790 May 2005 WO
2005053506 Jun 2005 WO
2005072625 Aug 2005 WO
2007018809 Feb 2007 WO
2008002961 Jan 2008 WO
2008016757 Feb 2008 WO
08033873 Mar 2008 WO
2008033871 Mar 2008 WO
2008033872 Mar 2008 WO
2008033874 Mar 2008 WO
2008054894 May 2008 WO
2008086258 Jul 2008 WO
2008124206 Oct 2008 WO
2008124463 Oct 2008 WO
2008130893 Oct 2008 WO
2008134355 Nov 2008 WO
2008144379 Nov 2008 WO
2009070896 Jun 2009 WO
2010043043 Apr 2010 WO
2011097311 Aug 2011 WO
2011139294 Nov 2011 WO
2013009901 Jan 2013 WO
2013173360 Nov 2013 WO
2014142948 Sep 2014 WO
2014144239 Sep 2014 WO
2014144262 Sep 2014 WO
2014144489 Sep 2014 WO
2014144757 Sep 2014 WO
2014144797 Sep 2014 WO
2015177612 Nov 2015 WO
16033016 Mar 2016 WO
16053834 Apr 2016 WO
2016085973 Jun 2016 WO
2016163939 Oct 2016 WO
18006045 Jan 2018 WO
2018025094 Feb 2018 WO
2018058036 Mar 2018 WO
2018075694 Apr 2018 WO
18098086 May 2018 WO
2018165334 Sep 2018 WO
2018165339 Sep 2018 WO
WO-2018165334 Sep 2018 WO
2019051343 Mar 2019 WO
2019164990 Aug 2019 WO
2021011795 Jan 2021 WO
2021016122 Jan 2021 WO
2021062385 Apr 2021 WO
2021062038 Apr 2021 WO
2021062394 Apr 2021 WO
2022165232 Aug 2022 WO
2022170269 Aug 2022 WO
Non-Patent Literature Citations (16)
Entry
PCT/US2019/ 018828 filed Feb. 20, 2019 International Preliminary Report on Patentability dated Aug. 27, 2020.
PCT/US2019/ 018828 filed Feb. 20, 2019 International Search Report and Written Opinion dated Jun. 13, 2019.
Ekchian Gregory James et al: “Quantitative Methods for In Vitro and In Vivo Characterization of Cell and Tissue Metabolism”, Jun. 11, 2018, XP055839281, retrieved from the internet on Sep. 8, 2021 : URL: https://dspace.mit.edu/bitstream/handle/1721.1/117890/1051211749-MIT.pdf?sequence=1&isAllowed=y.
PCT/US2021/035475 filed Jun. 2, 2021 International Search Report and Written Opinion dated Sep. 17, 2021.
PCT/US2021/ 035232 filed Jun. 1, 2021 International Search Report and Written Opinion dated Oct. 19, 2021.
PCT/US2021/028114 filed Apr. 20, 2021 International Search Report and Written Opinion dated Jul. 12, 2021.
PCT/US2020/ 053119 filed Sep. 28, 2020 International Search Report and Written Opinion dated Jan. 5, 2021.
PCT/US2020/052558 filed Sep. 24, 2020 International Search Report and Written Opinion dated Feb. 11, 2021.
PCT/US2020/053135 filed Sep. 28, 2020 International Search Report and Written Opinion dated Dec. 18, 2020.
PCT/US2021/ 046573 filed Aug. 18, 2021 International Search Report and Written Opinion dated Nov. 30, 2021.
PCT/US2021/ 047378 filed Aug. 24, 2021 International Search Report and Written Opinion dated Nov. 17, 2021.
PCT/US2021/ 048542 filed Aug. 31, 2021 International Search Report and Written Opinion dated Dec. 9, 2021.
PCT/US2021/ 049475 filed Sep. 8, 2021 International Search Report and Written Opinion dated Dec. 9, 2021.
PCT/US2022/014391 filed Jan. 28, 2022 International Search Report and Written Opinion dated Apr. 14, 2022.
PCT/US2022/015686 filed Feb. 8, 2022 International Search Report and Written Opinion dated May 25, 2022.
U.S. Appl. No. 17/035,336, filed Sep. 28, 2020 Restriction Requirement dated Jul. 26, 2022.
Related Publications (1)
Number Date Country
20210093354 A1 Apr 2021 US
Provisional Applications (1)
Number Date Country
62907438 Sep 2019 US